Skip to Main Content

Author Details

Susan Evans-Axelsson
Institution of Translational Medicine, Lund University
2012
17
11
PMIDPaper TitleJournal TitlePublished Year
37414703Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.Eur Urol2024
33277393Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.J Nucl Med2021
33786638Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer.Cancer Immunol Immunother2021
32194823Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study.Theranostics2020
30389819Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux.J Nucl Med2019
29747035Microscale radiosynthesis, preclinical imaging and dosimetry study of [<sup>18</sup>F]AMBF<sub>3</sub>-TATE: A potential PET tracer for clinical imaging of somatostatin receptors.Nucl Med Biol2018
30374743Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.EJNMMI Res2018
28546332Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer.J Nucl Med2017
28886116Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.PLoS One2017
26144873The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.Eur Urol2016
27111731Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.J Med Chem2016
26897720Radioimmunotherapy for Prostate Cancer--Current Status and Future Possibilities.Semin Nucl Med2016
25577038Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution.Nucl Med Biol2015
24753983Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein.Am J Nucl Med Mol Imaging2014
26116115Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6.EJNMMI Res2014
24982817Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.Am J Nucl Med Mol Imaging2014
22489659Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.Cancer Biother Radiopharm2012
  • 1 - 17 of 17

Recommended Authors

Johns Hopkins University School of Medicine
Career Start Year 2018
Number of shared co-authors 6
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 0
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 1
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Career Start Year 2003
Number of shared co-authors 4
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Career Start Year 2003
Number of shared co-authors 5
University of British Columbia
Career Start Year 2002
Number of shared co-authors 3
Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Career Start Year 2002
Number of shared co-authors 7
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 6
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 2
The Institute for Cancer Research
Career Start Year 1999
Number of shared co-authors 7
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 4
University of Washington School of Medicine
Career Start Year 1996
Number of shared co-authors 2
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Johns Hopkins School of Medicine
Career Start Year 1995
Number of shared co-authors 2
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 3
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 1990
Number of shared co-authors 1
University of British Columbia
Career Start Year 1987
Number of shared co-authors 6
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 2
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
University of California san francisco
Career Start Year 1985
Number of shared co-authors 7
Northwestern University
Career Start Year 1984
Number of shared co-authors 5
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 7
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 3
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 2
University of Washington
Career Start Year 1974
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1973
Number of shared co-authors 5
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Skane University Hospital, Lund University
Co-authored papers 10
university of california los angeles
Co-authored papers 4
David Geffen School of Medicine, university of california los angeles
Co-authored papers 3
university of california los angeles
Co-authored papers 2
Northeastern University
Co-authored papers 1
Astellas Pharma, Inc.
Co-authored papers 1
King's College London
Co-authored papers 1
University of Alberta
Co-authored papers 1
Aberdeen Royal Infirmary
Co-authored papers 1
University of Aberdeen
Co-authored papers 1
Columbia University
Co-authored papers 1
University of Guelph
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
St. Antonius Hospital
Co-authored papers 1
University of Oxford
Co-authored papers 1
Department of Hospital Services & Informatics
Co-authored papers 1
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 1
Careggi University Hospital
Co-authored papers 1
Liverpool University Hospitals
Co-authored papers 1
Biosystematics Group Wageningen University Wageningen The Netherlands.
Co-authored papers 1
European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL-INSERM
Co-authored papers 1
Co-authored papers 1
Urological Research Institute, IRCCS San Raffaele Hospital
Co-authored papers 1
Astellas Pharma, Inc.
Co-authored papers 1
Hippokrateion General Hospital of Thessaloniki
Co-authored papers 1
Institute of Computer Science, University of Tartu
Co-authored papers 1
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 1
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1